American International Group, Inc. Silverback Therapeutics, Inc. Transaction History

American International Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	N/A	-103 Reduced 0.84%	12,099 $0
Q4 2023 Feb 13, 2024	BUY	N/A	101 Added 0.83%	12,202 $0
Q3 2023 Nov 13, 2023	BUY	N/A	429 Added 3.68%	12,101 $0
Q2 2023 Aug 04, 2023	BUY	N/A	11,672 New	11,672 $0
Q2 2022 Aug 12, 2022	SELL	$2.9 - $4.44 $29,527 - $45,208	-10,182 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$3.51 - $6.74 $2,513 - $4,825	-716 Reduced 6.57%	10,182 $36,000
Q4 2021 Feb 11, 2022	SELL	$6.03 - $11.67 $1,965 - $3,804	-326 Reduced 2.9%	10,898 $73,000
Q3 2021 Nov 12, 2021	BUY	$9.98 - $35.22 $40,878 - $144,261	4,096 Added 57.46%	11,224 $112,000
Q2 2021 Aug 13, 2021	SELL	$24.71 - $44.28 $6,548 - $11,734	-265 Reduced 3.58%	7,128 $220,000
Q1 2021 May 07, 2021	BUY	$37.62 - $60.41 $278,124 - $446,611	7,393 New	7,393 $323,000

163

62.7M

872K

589K

Ticker SBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,473,800
Description
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.